Company Overview
- Headquarters
- 201 Jones Rd Suite 400, Waltham MA
- Website
- lajollapharmaceutical.com
- pa****@lajollapharmaceutical.com
- Phone
- (617) 715-****
- Employees
- 92
- Founded in
- 1989
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:LJP
- NAICS Code
- 5417, 32, 3254, 54171, 325, 541714, 541, 54
- SIC Code
- 87, 28, 873, 283
Financials & Stats
Revenue
$52B
Who is La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company is a subsidiary of Innoviva, Inc., operating as a company based in Waltham, Massachusetts. With a workforce of 92 employees, La Jolla Pharmaceutical Company focuses on bringing innovative therapies to patients battling life-threatening diseases. The company specializes in the commercialization of pharmaceuticals, primarily for the treatment of gastrointestinal and infectious diseases. La Jolla markets two key products: GIAPREZA® (angiotensin II) injection, used for the treatment of septic shock, and XERAVA® (eravacycline) for injection, designed to combat complicated urinary tract infections and other serious bacterial infections. La Jolla Pharmaceutical Company distinguishes itself by its commitment to developing and delivering therapies that significantly improve patient outcomes for those facing serious medical conditions. For further details about La Jolla Pharmaceutical Company and their products, please visit their website at www.ljpc.com.
Company Leadership
La Jolla Pharmaceutical Company Industry Tags
La Jolla Pharmaceutical Company Tech Stack
Companies Similar to La Jolla Pharmaceutical Company
Analyze industry trends and opportunities by examining competitors and companies comparable to La Jolla Pharmaceutical Company, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
51M | 272 | Cranbury, NJ | 2015 | |
50M | 59 | Foster City, CA | ||
50M | 74 | San Diego, CA | ||
50M | 181 | New Haven, CT | 2017 | |
50M | 58 | Carlsbad, CA |